Skip to main content

Haloperidol Lactate Injection

Last Updated: January 13, 2023
Status: Current

Products Affected - Description
    • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 1 mL vial, 25 count, NDC 00143-9501-25
    • Haloperidol lactate solution for injection, Hikma, 5 mg/mL, 10 mL vial, 1 count, NDC 00143-9502-01
Reason for the Shortage
    • Fresenius Kabi has haloperidol lactate injection available.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional has haloperidol lactate injection available.
    • Sagent has haloperidol lactate injection available.
Available Products
    • Haloperidol lactate injection, Fresenius Kabi, 5 mg/mL, 1 mL Simplist prefilled syringe, 24 count, NDC 76045-0737-10
    • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 1 mL vial, 25 count, NDC 63323-0474-01
    • Haloperidol lactate solution for injection, Fresenius Kabi, 5 mg/mL, 10 mL vial, 1 count, NDC 63323-0474-10
    • Haloperidol lactate solution for injection, Mylan Institutional (Viatris), 5 mg/mL, 1 mL vial, 25 count, NDC 67457-0426-12
    • Haloperidol lactate solution for injection, Sagent, 5 mg/mL, 1 mL vial, 10 count, NDC 25021-0806-01

Estimated Resupply Dates

    • Hikma has haloperidol lactate injection 5 mg/mL 1 mL vials on back order and the company cannot estimate a release date. The 5 mg/mL 10 mL vials are on back order and the company estimates a release date in first quarter 2023.

Updated

Updated January 13, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created December 9, 2020 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.